Ex vivo evaluation of intravitreal mesenchymal stromal cell viability using bioluminescence imaging

Abstract Background Bone marrow-derived mesenchymal stromal cell (MSC) therapy is a promising treatment for several degenerative ocular diseases; however, no reproducible method of monitoring these cells into the eye has been established. The aim of this study was to describe successful bioluminesce...

Full description

Bibliographic Details
Main Authors: Carolina Assis P. Vilela, Lucas Eduardo B. Souza, Rubens C. Siqueira, Rodrigo T. Calado, Dimas T. Covas, Jayter S. Paula
Format: Article
Language:English
Published: BMC 2018-06-01
Series:Stem Cell Research & Therapy
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13287-018-0909-y
_version_ 1818294700368461824
author Carolina Assis P. Vilela
Lucas Eduardo B. Souza
Rubens C. Siqueira
Rodrigo T. Calado
Dimas T. Covas
Jayter S. Paula
author_facet Carolina Assis P. Vilela
Lucas Eduardo B. Souza
Rubens C. Siqueira
Rodrigo T. Calado
Dimas T. Covas
Jayter S. Paula
author_sort Carolina Assis P. Vilela
collection DOAJ
description Abstract Background Bone marrow-derived mesenchymal stromal cell (MSC) therapy is a promising treatment for several degenerative ocular diseases; however, no reproducible method of monitoring these cells into the eye has been established. The aim of this study was to describe successful bioluminescence imaging (BLI) to detect viable luciferase-expressing MSC in the eye. Methods Human donor MSC in culture were transduced with 50 μl luciferase lentiviral vector (three viral particles/cell) prior to intraocular injection. Twenty-one right eyes of 21 rabbits were evaluated through BLI after receiving 1 × 106 luciferase-expressing MSC intravitreally. Contralateral eyes were injected with vehicle (phosphate-buffered saline (PBS)) and were used as controls. At seven different time points (1 h to 60 days), d-luciferin (40 mg/ml, 300 μl PBS) was injected in subsets of six enucleated eyes for evaluation of radiance decay through BLI analysis. CD90 and CD73 immunofluorescence was studied in selected eyes. Results Eyes injected with MSC showed high BLI radiance immediately after d-luciferin injection and progressive decay until 60 days. Mean BLI radiance measures from eyes with luciferase-expressing MSC were significantly higher than controls from 8 h to 30 days. At the thirtieth day, positive CD90- and CD73-expressing cells were observed only in the vitreous cavity of eyes injected with MSC. Conclusions Viable MSC were identified in the vitreous cavity 1 month after a single injection. Our results confirmed BLI as a useful and reliable method to detect MSC injected into the eye globe.
first_indexed 2024-12-13T03:35:55Z
format Article
id doaj.art-c03df426ae9e4003a5118ca150da97ac
institution Directory Open Access Journal
issn 1757-6512
language English
last_indexed 2024-12-13T03:35:55Z
publishDate 2018-06-01
publisher BMC
record_format Article
series Stem Cell Research & Therapy
spelling doaj.art-c03df426ae9e4003a5118ca150da97ac2022-12-22T00:01:03ZengBMCStem Cell Research & Therapy1757-65122018-06-01911710.1186/s13287-018-0909-yEx vivo evaluation of intravitreal mesenchymal stromal cell viability using bioluminescence imagingCarolina Assis P. Vilela0Lucas Eduardo B. Souza1Rubens C. Siqueira2Rodrigo T. Calado3Dimas T. Covas4Jayter S. Paula5Department of Ophthalmology, Otorhinolaryngology and Head and Neck Surgery, Ribeirão Preto Medical School, University of São PauloHemotherapy Center of Ribeirão Preto, Ribeirão Preto Medical School, University of São Paulo Ribeirão PretoDepartment of Ophthalmology, Otorhinolaryngology and Head and Neck Surgery, Ribeirão Preto Medical School, University of São PauloHemotherapy Center of Ribeirão Preto, Ribeirão Preto Medical School, University of São Paulo Ribeirão PretoHemotherapy Center of Ribeirão Preto, Ribeirão Preto Medical School, University of São Paulo Ribeirão PretoDepartment of Ophthalmology, Otorhinolaryngology and Head and Neck Surgery, Ribeirão Preto Medical School, University of São PauloAbstract Background Bone marrow-derived mesenchymal stromal cell (MSC) therapy is a promising treatment for several degenerative ocular diseases; however, no reproducible method of monitoring these cells into the eye has been established. The aim of this study was to describe successful bioluminescence imaging (BLI) to detect viable luciferase-expressing MSC in the eye. Methods Human donor MSC in culture were transduced with 50 μl luciferase lentiviral vector (three viral particles/cell) prior to intraocular injection. Twenty-one right eyes of 21 rabbits were evaluated through BLI after receiving 1 × 106 luciferase-expressing MSC intravitreally. Contralateral eyes were injected with vehicle (phosphate-buffered saline (PBS)) and were used as controls. At seven different time points (1 h to 60 days), d-luciferin (40 mg/ml, 300 μl PBS) was injected in subsets of six enucleated eyes for evaluation of radiance decay through BLI analysis. CD90 and CD73 immunofluorescence was studied in selected eyes. Results Eyes injected with MSC showed high BLI radiance immediately after d-luciferin injection and progressive decay until 60 days. Mean BLI radiance measures from eyes with luciferase-expressing MSC were significantly higher than controls from 8 h to 30 days. At the thirtieth day, positive CD90- and CD73-expressing cells were observed only in the vitreous cavity of eyes injected with MSC. Conclusions Viable MSC were identified in the vitreous cavity 1 month after a single injection. Our results confirmed BLI as a useful and reliable method to detect MSC injected into the eye globe.http://link.springer.com/article/10.1186/s13287-018-0909-yBioluminescenceCell transplantationCell viability assessmentIntravitreal injectionLuciferaseMesenchymal stromal cell
spellingShingle Carolina Assis P. Vilela
Lucas Eduardo B. Souza
Rubens C. Siqueira
Rodrigo T. Calado
Dimas T. Covas
Jayter S. Paula
Ex vivo evaluation of intravitreal mesenchymal stromal cell viability using bioluminescence imaging
Stem Cell Research & Therapy
Bioluminescence
Cell transplantation
Cell viability assessment
Intravitreal injection
Luciferase
Mesenchymal stromal cell
title Ex vivo evaluation of intravitreal mesenchymal stromal cell viability using bioluminescence imaging
title_full Ex vivo evaluation of intravitreal mesenchymal stromal cell viability using bioluminescence imaging
title_fullStr Ex vivo evaluation of intravitreal mesenchymal stromal cell viability using bioluminescence imaging
title_full_unstemmed Ex vivo evaluation of intravitreal mesenchymal stromal cell viability using bioluminescence imaging
title_short Ex vivo evaluation of intravitreal mesenchymal stromal cell viability using bioluminescence imaging
title_sort ex vivo evaluation of intravitreal mesenchymal stromal cell viability using bioluminescence imaging
topic Bioluminescence
Cell transplantation
Cell viability assessment
Intravitreal injection
Luciferase
Mesenchymal stromal cell
url http://link.springer.com/article/10.1186/s13287-018-0909-y
work_keys_str_mv AT carolinaassispvilela exvivoevaluationofintravitrealmesenchymalstromalcellviabilityusingbioluminescenceimaging
AT lucaseduardobsouza exvivoevaluationofintravitrealmesenchymalstromalcellviabilityusingbioluminescenceimaging
AT rubenscsiqueira exvivoevaluationofintravitrealmesenchymalstromalcellviabilityusingbioluminescenceimaging
AT rodrigotcalado exvivoevaluationofintravitrealmesenchymalstromalcellviabilityusingbioluminescenceimaging
AT dimastcovas exvivoevaluationofintravitrealmesenchymalstromalcellviabilityusingbioluminescenceimaging
AT jayterspaula exvivoevaluationofintravitrealmesenchymalstromalcellviabilityusingbioluminescenceimaging